Temozolomide (oral)

Temozolomide

Temozolomide
Temozolomide (brand names Temodar and Temodal Schering-Plough Corporation) is an oral alkylating agent which can be used for the treatment of Grade IV astrocytoma — an aggressive brain tumor, also known as glioblastoma multiforme as well as melanoma, a form of skin cancer. It is also indicated for Grade III Anaplastic Astrocytoma and not indicated for, but now used to treat oligodendroglioma brain tumors in some countries, replacing the older (and less well-tolerated) PCV regimen. The agent was developed by Malcolm Stevens and his team at Aston University in Birmingham, A derivative of imidazotetrazine, temozolomide is the prodrug of MTIC (3-methyl-imidazole-4-carboxamide)...

Temozolomide (oral) - List of case studies

Drugs

Oral enzyme replacement pills Oral etoposide (oral) Oral hypoglycemic Oral prednisone Oral progestogens ... Telebrix Temodal Temozolomide Temozolomide (oral) Tenormin Teriparatide Tetrabenazine ...

Metastatic well differentiated neuroendocrine carcinoma in liver

to high proliferation capacity and the liver metastases, temozolomide in combination with capecitabine might be an option. ...   Medicines : oral hypoglycemic, temozolomide, capecitabine.   Treatments : surgical ...

Diffuse Intra-Axial expansive Lesion of the Enchephalic Trunk not surgically investigated _3

would recommend outside of a clinical trial oral temozolomide or oral etoposide , or on or off a clinical trial, bevacizumab ... cortisone , chemotherapy , temozolomide (oral), oral etoposide (oral), bevacizumab, irinotecan, capecitablne, pain ...

JustAnswer.com